Literature DB >> 28663253

Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.

Hyo-Jung Choo1, Andaleb Kholmukhamedov1, ChengZing Zhou1, Shawn Jobe2.   

Abstract

OBJECTIVE: Phosphatidylserine exposure mediates platelet procoagulant function and regulates platelet life span. Apoptotic, necrotic, and integrin-mediated mechanisms have been implicated as intracellular determinants of platelet phosphatidylserine exposure. Here, we investigate (1) the role of mitochondrial events in platelet phosphatidylserine exposure initiated by these distinct stimuli and (2) the cellular interactions of the procoagulant platelet in vitro and in vivo. APPROACH AND
RESULTS: Key mitochondrial events were examined, including cytochrome c release and inner mitochondrial membrane (IMM) disruption. In both ABT-737 (apoptotic) and agonist (necrotic)-treated platelets, phosphatidylserine externalization was temporally correlated with IMM disruption. Agonist stimulation resulted in rapid cyclophilin D-dependent IMM disruption that coincided with phosphatidylserine exposure. ABT-737 treatment caused rapid cytochrome c release, eventually followed by caspase-dependent IMM disruption that again closely coincided with phosphatidylserine exposure. A nonmitochondrial and integrin-mediated mechanism has been implicated in the formation of a novel phosphatidylserine-externalizing platelet subpopulation. Using image cytometry, this subpopulation is demonstrated to be the result of the interaction of an aggregatory platelet and a procoagulant platelet rather than indicative of a novel intracellular mechanism regulating platelet phosphatidylserine externalization. Using electron microscopy, similar interactions between aggregatory and procoagulant platelets are demonstrated in vitro and in vivo within a mesenteric vein hemostatic thrombus.
CONCLUSIONS: Platelet phosphatidylserine externalization is closely associated with the mitochondrial event of IMM disruption identifying a common pathway in phosphatidylserine-externalizing platelets. The limited interaction of procoagulant platelets and integrin-active aggregatory platelets identifies a potential mechanism for procoagulant platelet retention within the hemostatic thrombus.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  blood platelet; cell death; cytosol; mitochondrial membrane; phosphatidylserine

Mesh:

Substances:

Year:  2017        PMID: 28663253      PMCID: PMC5560492          DOI: 10.1161/ATVBAHA.117.309473

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  37 in total

1.  Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin.

Authors:  L Alberio; O Safa; K J Clemetson; C T Esmon; G L Dale
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

2.  Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Authors:  Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

3.  Role of mitochondrial permeability transition pore in coated-platelet formation.

Authors:  Gyula Remenyi; Robert Szasz; Paul Friese; George L Dale
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-09       Impact factor: 8.311

Review 4.  Insights into platelet-based control of coagulation.

Authors:  Susanne M de Witt; Remco Verdoold; Judith M E M Cosemans; Johan W M Heemskerk
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

5.  Experimental hemostasis in normal dogs and dogs with congenital disorders of blood coagulation.

Authors:  T Hovig; H C Rowsell; W J Dodds; L Jorgensen; J F Mustard
Journal:  Blood       Date:  1967-11       Impact factor: 22.113

6.  Role of FcRgamma and factor XIIIA in coated platelet formation.

Authors:  Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

7.  Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3).

Authors:  Nikolay N Topalov; Alena O Yakimenko; Matthias Canault; Elena O Artemenko; Natalia V Zakharova; Anastasia A Abaeva; Marie Loosveld; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-26       Impact factor: 8.311

8.  Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells.

Authors:  Jun Suzuki; Daniel P Denning; Eiichi Imanishi; H Robert Horvitz; Shigekazu Nagata
Journal:  Science       Date:  2013-07-11       Impact factor: 47.728

9.  Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets.

Authors:  Wolfgang Bergmeier; Peter C Burger; Crystal L Piffath; Karin M Hoffmeister; John H Hartwig; Bernhard Nieswandt; Denisa D Wagner
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

Review 10.  The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.

Authors:  Andrew P Halestrap; Andrew P Richardson
Journal:  J Mol Cell Cardiol       Date:  2014-08-30       Impact factor: 5.000

View more
  18 in total

1.  An αIIbβ3- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis.

Authors:  Jian Jing; Yanna Sun
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

Review 2.  Platelet Signaling Pathways and New Inhibitors.

Authors:  Steven P Grover; Wolfgang Bergmeier; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04       Impact factor: 8.311

3.  In Vitro Effect of Mitochondria-Targeted Triphenylphosphonium-Based Compounds (Honokiol, Lonidamine, and Atovaquone) on the Platelet Function and Cytotoxic Activity.

Authors:  Héctor Montecino-Garrido; Diego Méndez; Ramiro Araya-Maturana; Juan Pablo Millas-Vargas; Sergio Wehinger; Eduardo Fuentes
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

4.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

5.  Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.

Authors:  Moua Yang; Andaleb Kholmukhamedov; Marie L Schulte; Brian C Cooley; Na'il O Scoggins; Jeremy P Wood; Scott J Cameron; Craig N Morrell; Shawn M Jobe; Roy L Silverstein
Journal:  Blood Adv       Date:  2018-11-13

6.  Platelet necrosis mediates ischemic stroke outcome in mice.

Authors:  Frederik Denorme; Bhanu Kanth Manne; Irina Portier; Alicia S Eustes; Yasuhiro Kosaka; Benjamin T Kile; Matthew T Rondina; Robert A Campbell
Journal:  Blood       Date:  2020-02-06       Impact factor: 25.476

Review 7.  CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function.

Authors:  Moua Yang; Roy L Silverstein
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.218

Review 8.  CD36 signaling in vascular redox stress.

Authors:  Moua Yang; Roy L Silverstein
Journal:  Free Radic Biol Med       Date:  2019-02-27       Impact factor: 8.101

Review 9.  The Neutrophil's Choice: Phagocytose vs Make Neutrophil Extracellular Traps.

Authors:  Angelo A Manfredi; Giuseppe A Ramirez; Patrizia Rovere-Querini; Norma Maugeri
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

Review 10.  Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.

Authors:  Stefan Handtke; Leif Steil; Andreas Greinacher; Thomas Thiele
Journal:  Front Med (Lausanne)       Date:  2018-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.